Free Trial

Coherus Oncology (CHRS) Insider Trading & Ownership

Coherus Oncology logo
$1.75 -0.01 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$1.78 +0.02 (+1.43%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Coherus Oncology (NASDAQ:CHRS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.08%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$73.99K
Get CHRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Coherus Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHRS Insider Buying and Selling by Quarter

Coherus Oncology Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2025
Mats Wahlstrom
Director
Sell99,988$0.74$73,991.12  
(Data available from 1/1/2013 forward)

CHRS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Coherus Oncology includes Dennis M Lanfear, and Mats Wahlstrom. Learn more on insiders at CHRS.

8.08% of Coherus Oncology stock is owned by insiders. Learn more on CHRS's insider holdings.

The following insider sold CHRS shares in the last 24 months: Mats Wahlstrom ($73,991.12).

Insiders have sold a total of 99,988 Coherus Oncology shares in the last 24 months for a total of $73,991.12 sold.



This page (NASDAQ:CHRS) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners